Search

Your search keyword '"Shankaran, Mahalakshmi"' showing total 84 results

Search Constraints

Start Over You searched for: Author "Shankaran, Mahalakshmi" Remove constraint Author: "Shankaran, Mahalakshmi" Database Unpaywall Remove constraint Database: Unpaywall
84 results on '"Shankaran, Mahalakshmi"'

Search Results

1. A protocol for remote collection of skeletal muscle mass via D3-creatine dilution in community-dwelling postmenopausal women from the Women’s Health Initiative

2. Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity

4. Associations Between D3Cr Muscle Mass and Magnetic Resonance Thigh Muscle Volume With Strength, Power, Physical Performance, Fitness, and Limitations in Older Adults in the SOMMA Study

5. Reductions in Functional Muscle Mass Measured Using D3creatine Dilution and Ability to Ambulate in Duchenne Muscular Dystrophy from Ages 4 – 24 Years

6. Associations between D3Cr muscle mass and MR thigh muscle volume with strength, power, physical performance, fitness, and limitations in older adults in the SOMMA study

7. D3‐creatine dilution, computed tomography and dual‐energy X‐ray absorptiometry for assessing myopenia and physical function in colon cancer: A cross‐sectional study

8. Supplementary Table 5 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

9. Supplementary Table 2 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

10. Supplementary Table 6 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

11. Supplementary Table 4 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

12. Supplementary Table 5 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

13. Supplementary Table 1 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

14. Data from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

15. Supplementary Table 2 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

16. Supplementary Table 6 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

17. Supplementary Table 4 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

18. Supplementary Table 1 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

19. Supplementary Table 3 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

20. Supplementary Table 3 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

21. Data from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

22. Application of the D3‐creatine muscle mass assessment tool to a geriatric weight loss trial: A pilot study

24. Supplementary Table 4 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

25. Supplementary Table 6 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

26. Supplementary Table 2 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

27. Supplementary Table 6 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

28. Supplementary Table 3 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

29. Supplementary Table 3 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

30. Data from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

31. Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

32. Supplementary Table 1 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

33. Supplementary Table 5 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

34. Supplementary Table 5 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

35. Supplementary Table 2 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

36. Supplementary Table 1 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

37. Supplementary Table 4 from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

38. Comparison of bioelectrical impedance indices for skeletal muscle mass and intracellular water measurements of physically active young men and athletes

39. The D3‐creatine dilution method non‐invasively measures muscle mass in mice

40. 24-hydroxycholesterol replacement rate measured in blood is a non-invasive biomarker of brain demyelination and remyelination in cuprizone-treated mice

41. Estimation of skeletal muscle mass in 4-year-old children using the D3-creatine dilution method

43. Adipocyte lipin 1 is positively associated with metabolic health in humans and regulates systemic metabolism in mice

45. Skeletal muscle mass can be estimated by creatine (methyl‐d3) dilution and is correlated with fat-free mass in active young males

49. Effects of Testosterone on Mixed-Muscle Protein Synthesis and Proteome Dynamics During Energy Deficit

Catalog

Books, media, physical & digital resources